# Design Therapeutics, Inc.: Form DEF 14A, filed Apr 23, 2026

- Company: [Design Therapeutics, Inc.](/companies/dsgn.md) (CIK 1807120)
- Form: DEF 14A
- Filed: 2026-04-23
- Accepted by EDGAR: Apr 23, 2026, 16:06 ET
- Period: 2026-04-23
- Accession: 0001193125-26-173678
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1807120/000119312526173678/dsgn-20260423.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1807120/000119312526173678/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1807120/000119312526173678/dsgn-20260423.htm

Filed Apr 23, 2026.
Source: SEC EDGAR, the filing index for accession 0001193125-26-173678. Last ingested by Listed: Oct 24, 2026, 15:07 ET. No prices; not investment advice.